Cramer-van der Welle, Christine M.
Verschueren, Marjon V.
Tonn, Merel
Peters, Bas J. M.
Schramel, Franz M. N. H.
Klungel, Olaf H.
Groen, Harry J. M.
van de Garde, Ewoudt M. W.
,
Kastelijn, E. A.
Vermeer, L. C.
van den Borne, B. E. E. M.
van Putten, J. W. G.
Schouwink, J. H.
Smit, A. A. J.
Funding for this research was provided by:
KWF Kankerbestrijding (SAN2016-7942, SAN2016-7942)
Article History
Received: 23 November 2020
Accepted: 25 February 2021
First Online: 18 March 2021
Competing interests
: EvdG reports research grants from the Dutch Cancer Society during the conduct of the study, and from AbbVie NL outside the submitted work. HG reports a grant from Boehringer-Ingelheim and other from BMS, Roche, Novartis, Merck and Pfizer, outside the submitted work. All remaining authors have declared no conflicts of interest.